This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Digital transformation has much to offer lifesciences as well as healthcare — and the synergies between the two can further optimize the power of digital health, clinicaltrials and patient outcomes.
Biotechnology company Tiziana LifeSciences has revealed plans to assess intranasal foralumab as a potential treatment for long Covid. Tiziana LifeSciences chief medical officer Matthew Davis said: “We anticipate entering into a Phase 2a placebo-controlled clinicaltrial upon successful feedback from the FDA.
Federation of Asian Biotech Associations’ (FABA) LifeSciences Innovation Cluster is now working to strengthen the global partnerships to propel an ecosystem for novel biologics and diagnostics.
Given these dire statistics, the need for innovative approaches in obesity clinicaltrials has never been more urgent. These trials are crucial for understanding and managing obesity while improving strategies to combat this complex health issue. Methods for endpoint protection in obesity clinicaltrials.
The surge in MASH cases stresses the need for early diagnosis, timely intervention and precise, reliable methodologies in clinicaltrials to evaluate new therapies effectively. Read on to gain insights from Medpace experts about advancements in imaging, histology and innovative techniques for MASH clinicaltrials.
In fact, mental health conditions are associated with a 10- to 25-year reduction in life expectancy , emphasizing the need for effective and accessible treatments. Its integral to peoples well-being to have a good mood and motivation in daily activities with their families and work life.
The Indian lifesciences sector is making strides by integrating quantum computing, artificial intelligence (AI), machine learning (ML), advanced analytics, big data, internet of things (IoT) and blockchain into their research and development efforts.
As the Union Budget approaches, the lifesciences sector anticipates substantial support to enhance innovation and investment in the development of new chemical entities (NCEs) and new biological entities (NBEs). The lifesciences sector in India has shown remarkable resilience […]
The same is true in lifesciences. As the technology develops, however, it will offer more opportunities to expedite drug discovery processes, streamline clinicaltrials, and speed up regulatory approvals. MGI puts the value of this contribution to clinical development at $15 billion to $25 b illion.
This prestigious acknowledgment places Cloudbyz among the top-performing companies globally, known for delivering scalable and intuitive CTMS solutions that empower clinical research teams. Our mission is to enable faster, more efficient trials, ultimately supporting the delivery of life-saving therapies.”
This week, were celebrating a significant milestone: the release of our 200th episode of the Xtalks LifeScience Podcast ! We’re excited to continue our journey by bringing you more in-depth conversations with industry leaders, highlighting the innovations and trends that shape the future of lifesciences.
By Luisa Sterkel & Joana Loureiro , Tenthpin Consultants The promise and potential of cell and gene therapies (CGT) has emerged in the recent past and currently over 1.500 CGT are registered for clinicaltrials holding great hope for the treatment of challenging and uncurable diseases.
In clinical research, diversity is more than a prerequisite for a successful drug — it’s a critical component that enhances the validity and applicability of clinicaltrial outcomes. Diversity Action Plans have now moved from being a “nice-to-have” to a “must-have” in clinicaltrial designs.
In the lifesciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all lifesciences subsidiaries are located in the US. After all, around a third of the world’s leading lifesciences corporations have their headquarters in the country. Industry clusters.
Anavex LifeSciences has secured new US intellectual property compositions patent for its ANAVEX 2-73 (blarcamesine). The patent number 11,661,405 has been issued by the US Patent and Trademark Office (USPTO) and is expected to remain effective until October 2036.
GSK has entered a strategic partnership with Wave LifeSciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. On completion of the first-in-patient clinicaltrial by Wave, GSK will be in charge of the development and marketing works.
Clinicaltrials have been steadily leaving the UK for years. of patients recruited to global trials were from the UK. Thats not to say we dont still have some clout (the UK ranks fourth globally for Phase II trials ), but the trending outflow needs to be addressed. In 2021, just 2.2%
This year, Camargo is highlighting one of our own, Manager of LifeScience Solutions Andrea Miller, who cared for her husband Tom throughout his battle with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease. We wanted to participate in a clinicaltrial. How was your husband diagnosed with ALS?
The lifescience industry is constantly evolving, making it difficult to stay ahead of the curve. Digital transformation is burgeoning and we aim to cover some of the dominant emerging technologies that are currently running the lifescience industry by storm.
Dr. Manson Brown’s Clinical Development and Scientific Innovation team are responsible for global clinicaltrial development strategy for the Aesthetic Medicine portfolio, covering pharmaceuticals and device. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
Experts in the life-sciences industry are of the view that doing away with human studies for new drugs in India is unscientific and risky as patients here have different anthropometry.
Lifescience podcasts have emerged as an invaluable tool for building connections with audiences in the digital era. Furthermore, we’ll explore the unique advertising opportunities that this platform offers, positioning brands at the forefront of the lifescience industry. The result?
In the dynamic world of lifesciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its LifeSciences Cloud marks a significant stride towards this goal.
As we step into 2024, the lifesciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. These companies are at various stages of research and clinicaltrials.
In the lifesciences, countless Black scientists, researchers and medical professionals have made groundbreaking discoveries that have significantly advanced our understanding of biology and medicine. They serve as inspiration for future generations of scientists from all backgrounds.
Stay up to date with the latest news in the lifesciences industry with highlights from clinicaltrials involving CSL, Arcturus, Sanofi, Nexviazyme, and REGENXBIO from the week of 5th to 9th February 2024.
In this episode, Vera spoke with Morgan Hanger, Executive Director of the ClinicalTrials Transformation Initiative (CTTI). CTTI is a public-private partnership dedicated to improving the quality and efficiency of clinicaltrials, with an ambitious “Transforming Trials 2030” vision.
The candidate is currently being evaluated in Phase II and Phase III clinicaltrials. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode. The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.
OncoImmune was founded in 2000 based on the scientific discoveries of the company’s founders who moved their lead product from a basic concept into clinicaltrials for multiple indications. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
BriaCell is developing cell therapies for the treatment of advanced breast cancer and has promising compounds, including Bria-IMT, that are currently being evaluated in clinicaltrials. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
Current Share Price: The announcement follows a $115 million Series D financing in December 2024, co-led by Frazier LifeSciences and Deep Track Capital, with participation from Janus Henderson Investors and Logos Capital.
The FNIH recently announced that the AMP Bespoke Gene Therapy Consortium has selected eight rare diseases for its clinicaltrial portfolio. Xtalks spoke with Dr. Silverthorm about the consortium’s new rare disease clinicaltrial portfolio. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
Whether it’s for a treatment for a chronic ambulatory condition, precision medicine or cell and gene therapy, there is a massive uptick in clinicaltrial complexity. It’s important to make sure that with this increase in clinicaltrial complexity, we don’t make our trials overly burdensome to sites or patients,” says Markham.
Over the next 12 months, the company expects to transition two or three other compounds into clinicaltrials. As part of Series B financing, Goldman Sachs Asset Management LifeSciences Investment head Amit Sinha and Lyell Immunopharma president and CEO Lynn Seely will join the board of managers of TORL BioTherapeutics.
VDRs may be used for asset sales, audit tenders, bankruptcies, due diligence processes, mergers & acquisitions, public and private debt and equity capital raising, clinicaltrials, and organisational restructuring. The post Virtual data room use for lifesciences M&A deals rising appeared first on Pharmaceutical Technology.
From enabling patient choice during clinicaltrials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables lifesciences teams to collaborate efficiently and effectively in 2023. Safety will create a single source of truth for content management.
As advancements in research forge ahead, it is imperative to ensure patients are informed about and can access potentially life-saving clinicaltrials. Tell us about your recent work regarding colorectal cancer clinicaltrials. How does the Colorectal Cancer Alliance support clinicaltrials for colorectal cancer?
BlueRock Therapeutics, a subsidiary of Bayer AG, is making waves in the treatment of Parkinsons disease by advancing its investigational cell therapy, bemdaneprocel, to a Phase III clinicaltrial. In the Phase I trial, 12 participants received the therapy and were observed for two years. As of 2023, there were approximately 2.7
At the beginning of September, Velocity Clinical Research topped Business North Carolina ’s 2024 Fast 40 list. For a clinicaltrials organization to achieve this level of scale is notable. Recruitment Clinicaltrial sites live and die by their ability to recruit patients into trials.
The push to increase diversity in clinicaltrials has gained momentum, but true progress requires more than regulatory mandates. In this webinar, industry leaders and patient advocates discussed how authenticity and the patient voice can be leveraged to enhance diversity in clinicaltrials.
The Foundation for the National Institutes of Health (FNIH) announced this week that the Accelerating Medicines Partnership Bespoke Gene Therapy Consortium (AMP BGTC) has selected eight rare diseases for its clinicaltrial portfolio.
Leading health solutions company CVS Health recently disclosed that its clinicaltrial business will shut down just two years after its initiation in May 2021. The company will gradually wind down its CVS Health ClinicalTrial Services unit with full exit by December 31, 2024.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content